{
  "slug": "epitalon-telomerase",
  "edition": "2026-10-09 revised",
  "authoring_model": "Sol 6.1",
  "authoring_provenance_note": "The document's own RED-TEAM SYNTHESIS NOTE records it as authored 2026-09-27 by OpenAI Codex under HSEF v5.4, then red-teamed and rewritten by Claude (Anthropic) on 2026-09-30. The banner uses the house attribution (Sol 6.1) as instructed; the discrepancy is flagged to the lead rather than silently reconciled.",
  "adversarial_reviewer": "Claude Opus 5.5 (Anthropic)",
  "review_date": "2026-10-14",
  "canonical_path": "consensus_consistency_audit_2026-10-09\\revised\\epitalon-telomerase\\epitalon-telomerase.review.md",
  "propagate_to": [],
  "divergent_copies": [],
  "level_before": "Γ",
  "level_after": "Γ",
  "descriptor_after": "Mechanistically plausible, partial system support",
  "confidence_before": "Low",
  "confidence_after": "Low",
  "confidence_band_rederived": "Lead two-step test applied: access depth struck as a determinant (F2), band re-derived from what remains and retained at Low.",
  "causal_role_before": "epiphenomenon",
  "causal_role_after": "epiphenomenon",
  "momentum_before": "Mechanistic only",
  "momentum_after": "Mechanistic only",
  "msd_changed": false,
  "pmids_checked": 23,
  "pmids_failed": 0,
  "retractions_or_eoc": 0,
  "claims_spot_checked": 31,
  "corrections_applied": 2,
  "counts_by_severity": {
    "Critical": 0,
    "Major": 0,
    "Minor": 2,
    "Editorial": 0
  },
  "validator": {
    "tool": "framework/hsef-hypothesis-review-v5/tools/validate_review.py",
    "result": "PASS",
    "fail_checks": [],
    "warn_checks": [],
    "passes": 34,
    "pre_edit_result_identical": true,
    "note": "The only review in group 5 that passes cleanly, because it is the only v5.4 review and therefore the only one carrying the mandatory lay summary."
  },
  "findings": [
    {
      "id": "F1",
      "severity": "Minor",
      "type": "internal_consistency",
      "location": [
        "§3, 'SHR mice: null central summaries, positive tail'"
      ],
      "original": "The most auditable mouse survival report used female outbred SHR mice, 54 per group, treated from three months of age until natural death [6].",
      "corrected": "The most auditable mouse survival report randomised female outbred SHR mice 54 per group and treated them from three months of age until natural death [6]; four mice per group were euthanised at twelve months for the cytogenetic study, so the paper reports its lifespan and tumour tables on 50 per group, which is the denominator behind the percentages below.",
      "evidence": "Both numbers are correct in PMID 14501183: the abstract and Methods say 54 per group, while Tables 5, 6 and 7 all print 'Number of mice 50 50'. The paragraph then quoted tumour percentages over a denominator of 50 with nothing to reconcile the shift.",
      "inherited_or_regression": "inherited",
      "level_impact": "none"
    },
    {
      "id": "F2",
      "severity": "Minor",
      "type": "confidence_rationale_from_access_depth",
      "location": [
        "§10 'Steelman and final adjudication'",
        "scorecard final_score.confidence_rationale (3 fields)"
      ],
      "original": "The confidence derivation listed, among its determinants, that two rodent survival reports are available only as English abstracts and two primaries are image-only scans.",
      "corrected": "Those two items are recorded as an access limitation rather than as reasons for the band; the derivation now rests only on evidence-side facts.",
      "evidence": "Lead policy for this round: how much of a paper the reviewer could read is neither evidence density nor reproducibility and never justifies a band. Step two was then applied and the band was retained at Low, because what remains is Low-band text several criteria over (small literature; eleven of twelve prior-edition sources from one connected research network; no organism-level result reproduced outside it; all three core data figures of the one independent cell study replaced by erratum). Striking an invalid downward reason can only raise a band, and the corpus is nowhere near 'extensive independent replication across labs, models, and assay modalities'.",
      "inherited_or_regression": "inherited",
      "level_impact": "none; confidence band unchanged"
    }
  ],
  "verification_highlights": [
    {
      "pmid": "14501183",
      "method": "primary PDF re-read (linked from reference 6)",
      "result": "Table 6: mean life span 456 ± 29 (saline) vs 455 ± 31 (Epitalon); median 512 vs 487, i.e. LOWER in the treated group exactly as this edition states and the prior edition did not; last-10% mean 709 ± 10.8 vs 803 ± 15.0 (+13.3%, P<0.01); maximum 739 vs 830 (+12.3%). Table 7: tumour-bearing mice 18 (36%) vs 16 (32%); leukaemia 6 vs 1. Results text: chromosome aberrations at 12 months 8.2 ± 0.41% vs 6.8 ± 0.21 (-17.1%, P<0.05). Table 2 shows food consumption significantly higher in treated mice at 5, 7, 9, 11, 13 and 16 months while Table 1 shows no body-weight difference, confirming the review's abstract-versus-table observation. Every figure verified."
    },
    {
      "pmid": "11087911",
      "result": "11-16% imago lifespan increase, Canton-S, egg-to-larva exposure only, and the paper's own statement that the increase did not depend on dose: all verified."
    },
    {
      "pmid": "28241208",
      "result": "35 cancers and 48 non-neoplastic diseases, 420,081 cases and 1,093,105 controls, glioma OR 5.27 (3.15-8.81), lung adenocarcinoma 3.19 (2.40-4.22), coronary heart disease 0.78, interstitial lung disease 0.09: all verified."
    },
    {
      "pmid": "34611362",
      "result": "472,174 UK Biobank participants and the 2.5-year life-expectancy difference at age 40 between the >1 SD shorter and >=1 SD longer groups: verified."
    },
    {
      "pmid": "22585399",
      "result": "AAV-TERT in 1- and 2-year-old mice, median lifespan +24% and +13%, no excess cancer versus littermates, no benefit from catalytically inactive TERT: all verified."
    },
    {
      "pmid": "40493162",
      "result": "high-glucose-injured human ARPE-19 retinal pigment epithelium, antioxidant and EMT mechanism, telomerase not measured: verified, and the review characterises it correctly as non-telomerase evidence."
    },
    {
      "pmid": "39788414",
      "result": "bovine cumulus-oocyte complexes, telomerase activated via Epitalon, improved maturation rate and post-thaw blastocyst hatching and implantation: verified."
    }
  ],
  "rejected_findings": [
    {
      "item": "headline letter Γ and weakest-link aggregation",
      "reason": "The submitted wording is a conjunction, which is what weakest-link is for; all five subclaims are Γ so all three rules converge, and the review says so rather than hiding the dependency. The Β and Δ cases are both argued and rejected on rubric text, with the one-rung-above case written first as v5 requires. hypothesis-index.md was confirmed to carry no entry, so no prescribed rule was deviated from, and index_rule_deviation is correctly empty."
    },
    {
      "item": "causal role epiphenomenon at step 2",
      "reason": "Answered in order, with the stopping point justified: at the scope the classification attaches to (human aging and healthspan) no study measures the mechanism, no necessity or rescue test exists in any system, and no mediation analysis links mechanism to outcome. The real cell-culture causal dependency is recorded at SC1's own scope rather than used to reach step 5."
    },
    {
      "item": "momentum, stability and divergence artifacts",
      "reason": "Momentum names five completed mechanistic items AND states that nothing identified addresses the boundary check, which is the definition of 'Mechanistic only' rather than the 'Decisive work underway' boilerplate. Stability names the absence of a moving trigger and cites the framework's 'Stable by definition' rule. Divergence quotes five artifacts, names the implied level, states the arithmetic (Γ to Ζ is three rungs) and bounds the judgement to this peptide's literature."
    },
    {
      "item": "cap applications",
      "reason": "Cap 1 holds SC1 at Γ; cap 2 bars the Mendelian-randomisation and polygenic telomere evidence from raising any subclaim above Β; cap 3 caps the AAV-TERT mouse result at Γ for endogenous-pathway claims. The epigenetics rubric's second Γ ceiling on the proximal chromatin step is recorded rather than assumed, and the cross-field lowest-ceiling rule is applied explicitly."
    },
    {
      "item": "'The earlier adversarial approval refers to its original edition'",
      "reason": "VERIFIED TRUE and left unaltered. prepublication-enrichment-2026-10-05/ADVERSARIAL_REVIEW.md records this case as 'Approved as reviewed' by Claude Opus 5.5 on 2026-10-06, 8/8 identifiers verified, grade unchanged. That approval's object was the dated research addendum, which is what 'its original edition' names."
    },
    {
      "item": "Consensus self-contradiction reported elsewhere in this batch",
      "reason": "Absent. REVIEWER NOTES and the Search-artifacts subsection describe the PubMed sweep, ClinicalTrials.gov searches and the FDA evaluation and deny no provider use. The splice itself declines to credit a shared template sentence about an amyloid-specific follow-up as a case-specific run for this topic."
    },
    {
      "item": "renderer bug: 'Best-supported rival' printing the nominal model",
      "reason": "Not applicable: the review has no such field, and in the competing-models table rank 1 is the non-nominal context-limited cellular response while the nominal telomerase-mediated geroprotection model sits at rank 2, with the prose naming rank 1."
    },
    {
      "item": "PMID 28241208 collective author",
      "reason": "PubMed's author array begins with an empty entry standing for the Telomeres Mendelian Randomization Collaboration. Reference 19 preserves the group name, so the collective-author builder defect did not fire. No other reference has a collective first author."
    },
    {
      "item": "PubMed title brackets and an MDPI article number",
      "reason": "References 5, 7, 10 and 21 are Russian-language articles whose PubMed titles are bracketed and whose reference lines drop the brackets; reference 17's '2691' is MDPI's article number rather than a page, confirmed by the pii. Both rejected by standing convention."
    },
    {
      "item": "reference 16 (PMID 40493162) used as telomerase evidence",
      "reason": "It is not. Every use of it in the review states that it attributes the effect to antioxidant and EMT-related action with no telomerase measurement, and cites it as support for the non-telomerase pleiotropic model and for the mediation gap."
    }
  ],
  "residual_limitations": [
    "The Al-Dulaimi cell paper's treatment durations, the telomerase-activity dissociation in the cancer lines and the C-circle and PML assays are body-level details absent from its abstract. The review declares complete full-text access to the corrected article and this pass confirmed the abstract contradicts none of them, but the corrected figures were not re-read — which, given that all three core data figures were replaced by erratum, is where any further check should go.",
    "The SHR primary is internally inconsistent about the leukaemia P value: Results text and abstract give a sixfold reduction at P < 0.01 while Table 7's footnote marks the same comparison P < 0.05. The review follows the Results text, which is defensible; the discrepancy is recorded rather than resolved."
  ],
  "package_level_strings_for_lead_to_propagate": [
    {
      "file_hint": "READER.html / website rendering / OVERVIEW.md",
      "old": "The most auditable mouse survival report used female outbred SHR mice, 54 per group, treated from three months of age until natural death [6].",
      "new": "The most auditable mouse survival report randomised female outbred SHR mice 54 per group and treated them from three months of age until natural death [6]; four mice per group were euthanised at twelve months for the cytogenetic study, so the paper reports its lifespan and tumour tables on 50 per group, which is the denominator behind the percentages below."
    },
    {
      "file_hint": "READER.html / website rendering / OVERVIEW.md",
      "old": "eleven of the twelve sources in the prior edition originate in one connected research network, no organism-level finding has been reproduced outside it, two rodent survival reports are available only as English abstracts, two primaries are unindexed scans, and the single independent cell-culture study required replacement of all three core data figures.",
      "new": "eleven of the twelve sources in the prior edition originate in one connected research network, no organism-level finding has been reproduced outside it, and the single independent cell-culture study required replacement of all three core data figures. The band rests on those evidence-side facts alone; that two rodent survival reports are available only as English abstracts and two primaries are unindexed scans is an access limitation recorded in REVIEWER NOTES, not a determinant of confidence."
    }
  ],
  "approval": "Following adversarial review and the corrections listed above, the revised document is approved. — Claude Opus 5.5 (Anthropic), 2026-10-14.",
  "lead_policy_applied": {
    "confidence_two_step_test": "Lead policy, round 2: (1) strike access depth as a confidence determinant everywhere; (2) re-derive the band from what remains, raising it only if access depth was the sole thing holding it down and the evidence meets the High text. Applied to this case; see the confidence finding for the outcome.",
    "momentum_decisive_work": "Lead policy, round 2: 'Decisive work underway' requires work actually being run that could cross the next threshold; a completed publication or trial never satisfies it, even when the artifact names a real study.",
    "false_approval_boilerplate": "Lead policy, round 2: the 2026-10-09 splice inserted 'The earlier adversarial approval refers to its original edition' unconditionally. Verify against prepublication-enrichment-2026-10-05/ADVERSARIAL_REVIEW.md before changing; rescope only where no earlier approval exists.",
    "renderer_best_supported_rival": "Lead policy, round 2: check the score card's is_nominal / rank_in_tournament fields; fix the prose, not the data, if the nominal is printed as the rival."
  }
}